It said it plans to double its Ireland-based software and technology team to support innovation, technology development, and product development, including roles such as mobile, AWS, and full-stack software developers, and algorithm/machine learning engineers.It focuses on technology using sensors to manage patients with chronic diseases in their homes.
Mick Farrell, CEO of ResMed, said this latest investment will support the continued growth of RedMed's product portfolio to meet the needs of patients across Ireland, Europe and the world. Mary Buckley, Executive Director of IDA Ireland said continued investment in the area of research and development is central to IDA Ireland's strategy 'Driving Recovery and Sustainable Growth 2021-2024’.
Source: Tech Daily Report (techdailyreport.net)